CIK 0001620463 · Non-accelerated filer<br>Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 453368487
- Phone
- (425) 620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 85 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | Litton Mark James President and CEO | Option exercise · Restricted Stock Units | −108,333 | 216,667 | ||
| 2024-12-31 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise | +36,667 | 139,271 | ||
| 2024-12-31 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units | −36,667 | 73,333 | ||
| 2024-12-31 | Renninger Robert VP of Finance | Option exercise | +12,359 | 92,605 | ||
| 2024-12-31 | Renninger Robert VP of Finance | Option exercise · Restricted Stock Units | −12,359 | 24,718 | ||
| 2024-12-31 | Worthington Mark General Counsel and CCO | Option exercise | +36,667 | 92,245 | ||
| 2024-12-31 | Worthington Mark General Counsel and CCO | Option exercise · Restricted Stock Units | −36,667 | 73,333 | ||
| 2024-11-18 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award | +9,920 | $0.55 | $5K | 102,604 |
| 2024-11-18 | Renninger Robert VP of Finance | Grant or award | +3,651 | $0.55 | $2K | 80,246 |
| 2024-11-18 | Worthington Mark General Counsel and CCO | Grant or award | +3,651 | $0.55 | $2K | 55,578 |
| 2024-10-03 | Litton Mark James President and CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2024-10-03 | Litton Mark James President and CEO | Grant or award · Restricted Stock Units | +325,000 | 325,000 | ||
| 2024-10-03 | Litton Mark James President and CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2024-10-01 | Renninger Robert VP of Finance | Grant or award · Restricted Stock Units | +37,077 | 37,077 | ||
| 2024-10-01 | Renninger Robert VP of Finance | Grant or award · Stock Option (Right to Buy) | +37,077 | 37,077 | ||
| 2024-10-01 | San Martin Javier CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +140,000 | 140,000 | ||
| 2024-10-01 | San Martin Javier CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2024-10-01 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award · Restricted Stock Units | +110,000 | 110,000 | ||
| 2024-10-01 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2024-10-01 | Worthington Mark General Counsel and CCO | Grant or award · Restricted Stock Units | +110,000 | 110,000 |
Page 7 of 10 · 187 trades